跳至主要内容
临床试验/ACTRN12621000563864
ACTRN12621000563864已完成2 期

Effect of low dose atropine eye drops on ocular changes during accommodation in children and young adults with myopia

Queensland University of Technology0 个研究点目标入组 31 人开始时间: 2021年5月13日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
6 Years 至 25 Years(—)
性别
All

入选标准

  • Healthy myopic children, adolescents, and young adults aged 6 to 25 years and with a myopic refractive error between -0.50 and -5.00 DS, and no greater than 1.00 D of astigmatism or anisometropia. Participants will currently be corrected with spectacles or contact lenses.

排除标准

  • Current or previous use of myopia control treatments (atropine, OrthoK, peripheral defocus soft contact lenses or spectacle lenses)
  • Amblyopia or strabismus
  • Stereopsis of 200 seconds of arc or greater
  • Monocular amplitude of accommodation of less than 8 D
  • Best corrected visual acuity (BCVA) poorer than 0.1 logMAR in both eyes, or greater than 1 line (0.1 logMAR) difference in VA between eyes
  • History of ocular surgery
  • History of significant ocular infection or injury
  • Known allergy to atropine, tropicamide, or benzalkonium chloride (BAK)
  • Known angle closure glaucoma, or temporal VH ratio <0.3:1 in either eye
  • Intraocular pressure greater than 21 mmHg in either eye
  • Current use of: anticholinergics, antiglaucoma medications, antimyasthenics, potassium drugs, carbachol/physostigmine/pilocarpine, no CNS depressants (such as antiemetics, phenothiazines, or barbiturates).
  • History of Down's syndrome, spastic paralysis, or brain damage.

研究者

相似试验